FORA Capital’s Exelixis EXEL Stock Holding History

FORA Capital’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,851	Closed	-$311K	–	507
2022 Q1	$311K	Buy	+13,851	New	+$271K	0.06%	378
2020 Q3	–	Sell	-5,442	Closed	-$129K	–	748
2020 Q2	$129K	Buy	5,442 +3,222	+145%	+$74.7K	0.04%	435
2020 Q1	$38K	Buy	+2,220	New	+$40.6K	0.01%	830

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FORA Capital's EXEL Position: Q2 2022 in Review

FORA Capital sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 13,851 shares — an estimated $311K sold.

FORA Capital first reported a position in EXEL in Q1 2020 and held it in 3 quarters. The position peaked at $311K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

FORA Capital reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
FORA Capital sold 13,851 Exelixis shares in Q2 2022, an estimated $311K.
FORA Capital first reported a position in Exelixis in Q1 2020 and held it in 3 quarters.
FORA Capital's Exelixis position peaked at $311K in Q1 2022.
373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on FORA Capital's 13F filing for Q2 2022, filed 11 Aug 2022.